Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Compared with cessation of behavioral weight management programs, weight regain was faster after cessation of medications (by 0.3 kg/month), independent of initial weight loss.

Stopping weight loss medication led to weight regain and reversed improvements in cardiometabolic markers in under 2 years, ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

A large review found that people who stopped taking GLP-1 drugs regained weight nearly twice as fast as people who gave up ...

Rapid Weight Loss Centers' 20-Year Approach to Real Food and Sustainable Results Shares Core Principles with Federal ...

One simple thing could prevent people using the ‘miracle’ drugs from sustaining long-term health consequences.

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility ...

As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.